January 19, 2015 FIVE PRIME Written By John McCamant Our top speculative idea for 2015 a classic early-stage platform; the company is a leader in the discovery of innovative protein therapeutics, explains John McCamant, editor of The Medical Technology Stock Letter. Five Prime (FPRX) has built an extremely impressive library comprised of more than 5,600[…]
Tag: FPRX
Bios Go From 1st To Worst, Is A Bottom Near? New Recommendation
Five Prime Therapeutics’ (FPRX) Protein Platform Technology Ready For Prime Time – Five Prime is a classic early-stage platform company with, in our view, a proprietary and powerful technology based on management’s broad experience and unique understanding of proteins.
MTSL Issue #776 – Bios Go From First To Worst – Have We Reached Bottom?
April 3, 2014 Below is a pdf for MTSL Issue #776 of the Medical Technology Stock Letter.
To access this post, you must have an active subscription to the Medical Technology Stock Letter. Please login if you are a current subscriber. Thank you.